AstraZeneca praises UAE for vaccination rollout and testing strategy

أسترازينيكا تشيد باستراتيجية دولة الإمارات

AstraZeneca has applauded the UAE’s impactful vaccination campaigns which has created increased trust and early uptake resulting in over 12.1 million doses in the UAE to date AstraZeneca to deliver keynote session on Oxford University and AstraZeneca’s partnership towards broad and equitable access to COVID-19 vaccine at Arab Health’s inaugural Pharma and Drug Discovery Conference on the 21 June Arab Health to take place from 21-24 June at the Dubai World Trade Centre A Government Affairs Director from AstraZeneca, the developer of one of the leading COVID-19 vaccines in partnership…

Alpho: AstraZeneca protects its vaccine, yet the company’s shares continue to remain under pressure

Alpho: AstraZeneca protects its vaccine, yet the company’s shares continue to remain under pressure

Dubai, United Arab Emirates,  (AETOSWire): In the last few weeks, the public has feared the danger of blood clots possibly caused by AstraZeneca vaccine. However, the company denied the charges last week after examining 17 million people who had been vaccinated in Europe and Great Britain. AstraZeneca’s statement was later supported even by the European Medicines Agency (EMA). Nevertheless, Norwegian scientists claim that their research supports the fear of public. And so, after some positive news, AstraZeneca’s stock reappeared under pressure. While AstraZeneca’s stock was traded at £71 per share…